Table 1.
Year | First Author | Journal | Study Design | Country | Sample Size | % of HIV-infected on ART | |
---|---|---|---|---|---|---|---|
HIV-infected | HIV-uninfected | ||||||
2005 | Thiebaut | Antivir Ther | Prospective Cohort | 21 countries (Europe, US and Australia) | 17,179 | 0 | 84% |
2006 | Crane | AIDS | Prospective Cohort | U.S.A. | 444 | 0 | 100% |
2006 | Palacios | HIV Med | Prospective Cohort | Spain | 95 | 0 | 100% |
2008 | Baekken | Nephrol Dial | Cross-sectional | Norway | 495 | 2091 | 72% |
2008 | Baekken | J Hypertens | Prospective Cohort | Norway | 542 | 24,968 | 71% |
2009 | Crane | HIV Med | Cross-Sectional | U.S.A. | 347 | 0 | 69% |
2012 | Freitas | J Clin Hypertens | Cross-Sectional | Portugal | 368 | 0 | 100% |
2013 | Glyn | J Hum Hypertens | Cross-Sectional | South Africa | 53 | 129 | 0% |
2013 | Hadigan | Am J Nephrol | Prospective Cohort | U.S.A. | 182 | 0 | 100% |
2013 | Manner | HIV Med | Prospective Cohort | Norway | 42 | 0 | 0% |
2013 | Manner | J Clin Hypertens | Prospective Cohort | Norway | 434 | 0 | 57% |
2014 | Morimoto | Nutrition | Cross-Sectional | Brazil | 285 | 0 | 79% |
2014 | Peck | BMC Medicine | Cross-Sectional | Tanzania | 301 | 153 | 50% |
2014 | Tenorio | J Infect Dis | Case-Control | U.S.A. | 458 | 0 | 100% |
2015 | Rokx | AIDS Res Hum | Clinical Trial | Netherlands | 50 | 0 | 100% |
2015 | Wensink | PLoS One | Cross-Sectional | South Africa | 903 | 0 | 87% |
2016 | Castley | PLoS One | Cross-Sectional | Australia | 475 | 0 | 77% |
2016 | Maffongelli | AIDS | Prospective Cohort | Italy | 116 | 0 | 100% |
2016 | Nduka | Int J Cardiol | Cross-sectional | Nigeria | 406 | 0 | 75% |
2016 | Pirro | Sci Rep | Cross-Sectional | Italy | 170 | 0 | 100% |
2016 | van Zoest | Clin Infect Dis | Prospective Cohort | Netherlands | 527 | 517 | 95% |
2017 | Ascher | Hypertension | Prospective Cohort | U.S.A. | 823 | 267 | 59% |
2017 | Ding | AIDS Res Hum | Cross-Sectional | China | 345 | 345 | 87% |
2017 | Rodriguez-Arboli | PLoS One | Prospective Cohort | Tanzania | 834 | 0 | 76% |